Copyright
©The Author(s) 2015.
World J Gastroenterol. Oct 21, 2015; 21(39): 11044-11052
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.11044
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.11044
Table 1 Non-invasive serum tests for the assessment of liver fibrosis and corresponding stages of alcoholic liver disease diagnosed
Test | Variables | ALD stage assessed |
AST:ALT ratio | ALT, AST | ≥ F1, F4 |
HA | HA | F4 |
PGA | PT, GGT, apolipoprotein-A1 | F4 |
PGAA | PT, GGT, apolipoprotein-A1, α2-macroglobulin | |
FibroTest® | Haptoglobin, α2-macroglobulin, apolipoprotein-A1, bilirubin, GGT | ≥ F3, F4 |
FibrometerA® | Age, weight, glucose, AST, ALT, PLT count, ferritin | ≥ F3, F4 |
FIB-4 | Age, AST, ALT, platelet count | ≥ F3 |
Hepascore® | Age, sex, bilirubin, GGT, α2-macroglobulin, HA | ≥ F3, F4 |
APRI | AST, platelet count | ≥ F2, F4 |
ELF test™ | HA, PIIINP, TIMP-1 | ≥ F3, F4 |
Forns index | Age, platelet count, total cholesterol, GGT | ≥ F3, F4 |
- Citation: Lombardi R, Buzzetti E, Roccarina D, Tsochatzis EA. Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease. World J Gastroenterol 2015; 21(39): 11044-11052
- URL: https://www.wjgnet.com/1007-9327/full/v21/i39/11044.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i39.11044